Cytoplasmic proteins that regulate signal transduction or induce cellular transformation, including cytoplasmic protein-tyrosine kinases, p21w GTPase-activating protein (GAP), phospholipase Cy, and the v-crk oncoprotein, possess one or two copies of a conserved noncatalytic domain, Src homology region 2 (SH2). Here we provide direct evidence that SH2 domains can mediate the interactions of these diverse signaling proteins with a related set ofphosphotyrosine ligands, including the epidermal growth factor (EGF) receptor. In src-transformed cells GAP forms heteromeric complexes, notably with a highly tyrosine phosphorylated 62-kDa protein (p62). The stable association between GAP and p62 can be specifically reconstituted in vitro by using a bacterial polypeptide containing only the N-terminal GAP SH2 domain. The efficient phosphorylation of p62 by the v-Src or v-Fps tyrosine kinases depends, in turn, on their SH2 domains and correlates with their transforming activity. In lysates of EGF-stimulated cells, the N-terminal GAP SH2 domain binds to both the EGF receptor and p62. Fusion proteins containing GAP or v-Crk SH2 domains complex with similar phosphotyrosine proteins from src-transformed or EGF-stimulated cells but with different efficiencies. SH2 sequences, therefore, form autonomous domains that direct signaling proteins, such as GAP, to bind specific phosphotyrosine-containing polypeptides. By promoting the formation of these complexes, SH2 domains are ideally suited to regulate the activation of intracellular signaling pathways by growth factors.
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The Src homology region 2 (SH2) domain was initially identified as a noncatalytic region of --100 amino acids that is conserved among cytoplasmic (nonreceptor) tyrosine kinases (1, 2) . Genetic and biochemical analysis of the Fps and Src tyrosine kinases suggests that their SH2 domains interact with and regulate the adjacent kinase domain and may also form binding sites for proteins phosphorylated by the kinase domain (3) (4) (5) (6) (7) (8) (9) (10) . Consistent with this view, the v-Crk retroviral oncoprotein, which consists primarily of an SH2 domain (11, 12) , activates an endogenous tyrosine kinase and forms complexes with several phosphotyrosine proteins in v-crktransformed cells (11, 13, 14) . The v-crk gene product also possesses a distinct motif, Src homology region 3 (SH3), found in a number of cytoskeletal and SH2-containing proteins (11, 12, 15, 16) (Fig. 1) .
Phospholipase Cy (PLCy) and p2lras GTPase-activating protein (GAP) each contain two adjacent SH2 domains related in structure to one another and to the SH2 domains of tyrosine kinases (9, (17) (18) (19) diacylglycerol and inositol triphosphate and, therefore, plays a central role in the activation of protein kinase C and the mobilization of intracellular calcium (20) . GAP stimulates the intrinsic GTPase activity of p21s and, hence, returns p2l's from the active GTP-bound state to the inactive GDP-bound form (21) . GAP interacts with the presumed effector region of p21's (22, 23) , suggesting that it might also be the Ras target or might modify the association of p21lms with its target.
PLCy forms a physical complex with activated epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) receptors (EGFRs and PDGFRs), is a substrate for receptor-catalyzed tyrosine phosphorylation, and apparently couples the PDGFR to phosphatidylinositol turnover (24) (25) (26) (27) . GAP is phosphorylated by a variety of oncogenic tyrosine kinases, as well as by the EGFR and PDGFR (28) (29) (30) (31) . GAP forms a complex with the PDGFR, which is dependent upon hormone-binding and receptor kinase activity and is potentiated by receptor autophosphorylation (30, 31) . These results indicate that GAP may link tyrosine kinases to the Ras signaling pathway. Activated tyrosine kinases that phosphorylate GAP also phosphorylate two proteins of 62 and 190 kDa (p62 and p190), which coimmunoprecipitate in a complex with GAP (28). Here we provide direct evidence that SH2 domains endow proteins such as GAP, v-Crk and p60vsrc with the potential to form complexes with specific tyrosine phosphorylated ligands. We suggest that SH2 domains are critical in regulating the intracellular response to growth factors.
MATERIALS AND METHODS
Cell Culture and Antibodies. Growth conditions, 32P, labeling, EGF treatment, and immunoprecipitation of RlhER (obtained from M. Weber, University of Virginia, Charlottesville), Rat-2, and Rat-2 cells expressing v-src or v-fps genes were as described (7, 9, 28) . Polyclonal rabbit antibodies against human GAP residues 171-448 or phosphotyrosine have been described (28, 32 (34) . Cells were washed with 1 ml of 50 mM Tris HCl, pH 7.5/10% (wt/vol) sucrose. Collected cells were resuspended in 1 ml of ice-cold PLCLB (50 mM Hepes, pH 7.0/150 mM NaCl/10o glycerol/1% Triton X-100/1.5 mM MgCl2/1 mM EGTA/100 mM NaF/10 mM NaPPj/1 mM Na3VO4/1 mM phenylmethylsulfonyl fluoride/aprotinin and leupeptin each at 10 ,tg/ml), sonicated 6 times for 10 sec each, and clarified by centrifugation at 15,000 X g for 15 min. Sonication and all subsequent steps were done at 4°C. Supernatants were incubated with 40 ,ul of anti-trpE serum and 30 ,ul of protein A-Sepharose beads. After being gently mixed for 90 min, the immune complexes were washed 3 times with HNTG (20 mM Hepes, pH 7.0/150 mM NaCl/ 0.1% Triton X-100/10% glycerol/i mM Na3VO4) and divided into four equal aliquots. Similar amounts of the different TrpE fusion proteins were detected in these immune complexes by immunoblotting with anti-TrpE antiserum.
For in vitro binding experiments, 5 x 106 nonradioactive or 32P-labeled cells were lysed in 1 or 2 ml of PLCLB and clarified as described below. One milliliter of clarified lysate was incubated with one aliquot of an anti-trpE immune complex. After being mixed by gentle inversion for 90 min at 4°C, the immune complexes were recovered by centrifugation, washed three times with HNTG, resuspended in 40 ,ul of SDS sample buffer, and heated at 100°C for 3 min.
Immunoblotting. Cell lysates (prepared as in ref. 9; 25 ,g of protein per lane), immunoprecipitates, and bacterial complexes were resolved by SDS/PAGE and transferred to nitrocellulose in a semi-dry blotting apparatus at 0.8 mA cm 2 for 60 min. Blots were analyzed by autoradiography (32P-labeled samples) or were blocked and then probed with anti-EGFR antiserum (1:200 dilution) or antiphosphotyrosine antibodies as described (9) . Antiphosphotyrosine blots of whole-cell lysates were probed with 10 ,uCi of 1251I-labeled protein A (2-10 ,Ci/,tg; 1 Ci = 37 GBq; New England Nuclear), whereas all other blots were probed with 5 ACi of high-specific-activity '25I-labeled protein A (35 tuCiltg, Amersham). Blots were exposed to Kodak XAR film at -750C with an intensifying screen. RESULTS GAP and Crk SH2 Domains Bind a Related Set of Phosphotyrosine-Containing Proteins. The disposition of SH2 and SH3 domains within several signaling and transforming proteins is shown in Fig. 1 . We initially used GAP to test whether these regions might be involved in protein-protein interactions. Different regions ofGAP were expressed in bacteria as fusion proteins joined to a 37-kDa TrpE protein (Fig. 1) . TrpE-GAP-SH2 contains almost precisely the two GAP SH2 domains and the intervening SH3 sequence. In contrast, TrpE-GAP-C contains the C-terminal half of GAP, including all residues required to stimulate p21's GTPase activity (35) . As controls we used the TrpE protein by itself and a TrpE-PLCy fusion protein containing C-terminal PLCy catalytic sequences. These TrpE fusion proteins were immunoprecipitated with anti-TrpE antiserum. To investigate whether these polypeptides could form specific complexes with proteins from src-transformed cells, the immunoprecipitates were incubated with a lysate of Rat-2 v-src cells and analyzed for associated proteins by immunoblotting with antiphosphotyrosine antibodies. TrpE, TrpE-PLCy, and TrpE-GAP-C, which lack SH2 sequences, did not retain any phosphotyrosine-containing proteins from the Rat-2 v-src lysate. However, TrpE-GAP-SH2 bound a 62-kDa phosphotyrosine protein, as well as variable amounts of a 130-kDa protein ( Fig.  2A) . The 62-kDa protein comigrated with p62 immunoprecipitated with anti-GAP antibodies from Rat-2 v-src cells. As a more direct test of their binding activities, the TrpE fusion proteins were incubated with a lysate of Rat-2 v-src cells that had been metabolically labeled with 32P1. Again, TrpE-GAP-SH2 specifically bound a 62-kDa phosphoprotein that comigrated with GAP-associated p62 ( Fig. 2A) The binding sites for p62 and p130 were more precisely ascribed to the N-terminal SH2 domain of GAP (GAP-SH2(N), Fig. 1 ), which efficiently bound p62 and p130 from Rat-2 v-src cells (Fig. 2B) . To investigate whether these phosphotyrosine-containing proteins might be more general ligands for SH2-containing proteins, similar experiments were done with a TrpE-v-Crk fusion protein (Fig. 1) . TrpEv-Crk also bound two phosphotyrosine-containing proteins when incubated with a Rat-2 v-src lysate, which likely correspond to p62 and p130 (Fig. 2B) . TrpE-v-Crk bound p130 more efficiently than did TrpE-GAP-SH2 and also associated with a distinct 70-kDa tyrosine phosphorylated protein (p70). In lysates of normal Rat-2 cells TrpE-GAP-SH2 bound a small amount of p62, whereas TrpE-v-Crk formed more readily detectable complexes with p130 and p70 (Fig. 2B) . It is of interest that phosphotyrosine-containing proteins of this size are associated with p475akgcrk in v-crktransformed chicken embryo fibroblasts and bind bacterial v-Crk in lysates of v-crk-transformed cells (11, 13, 14) . These results indicate that the GAP and Crk SH2 domains have distinct but overlapping binding specificities. They bind common phosphotyrosine-containing ligands but apparently with different efficiencies.
The N-Terminal GAP SH2 Domain Binds Activated EGF 7) , TrpE-GAP-SH2(N) (lanes 2 and 8), TrpE-GAP-SH2(C) (lanes 3 and 9), TrpE-GAP-SH2 (lanes 4 and 10), and TrpE-v-Crk (lanes 5 photyrosine-containing proteins associated with immobilized TrpE fusion proteins before EGF stimulation (Fig. 3A) or with TrpE-GAP-C after EGF addition (data not shown). However, TrpE-GAP-SH2, TrpE-GAP-SH2(N), and TrpEv-Crk precipitated two tyrosine phosphorylated proteins from lysates of EGF-stimulated cells, with mobilities of 62 and 180 kDa (Fig. 3A) . The 62-kDa protein comigrated with p62 precipitated from the EGF-stimulated lysate with anti-GAP antibodies. The 180-kDa band comigrated with EGFR immunoprecipitated from the same lysate and was recognized by anti-EGFR antibodies on an immunoblot (Fig. 3B) and was phosphorylated on tyrosine in an in vitro kinase reaction (data not shown). These data show that the 180-kDa protein is the EGFR and that its association with SH2 domains is clearly dependent on prior EGF stimulation (Fig.  3B) . TrpE-v-Crk bound the EGFR more effectively than the GAP SH2 fusion proteins but was less efficient in p62-binding ( Fig. 3 A and B, lanes 5 ).
Fps and Src SH2 Domains Are Required for Tyrosine
Phosphorylation of p62 and GAP. p62 is rapidly and abundantly phosphorylated by activated v-Src and v-Fps tyrosine kinases (28) . The v-Fps SH2 domain, and Glu-832 in particular, have been previously implicated in recognition of a 62-kDa protein whose phosphorylation correlates with transformation (9) . We, therefore, tested whether this substrate corresponds to p62, which displays an affinity for SH2 domains in vitro (see above). Direct comparison revealed that GAP-associated p62, precipitated with anti-GAP antibodies from cells transformed by wild type v-fps, comigrated with the prominent SH2-dependent 62-kDa substrate identified in the whole-cell lysate. Furthermore, little phosphotyrosinecontaining p62 could be detected in anti-GAP immunoprecipitates from cells expressing a v-fps mutant with a substitution of lysine for Glu-832 in the SH2 domain (Fig. 4A) . GAP itself is a relatively poor substrate for P130m-fPs (28); prolonged exposure revealed that GAP tyrosine phosphorylation also depends on the v-Fps SH2 domain. A series of in-phase linker-insertion and deletion mutations constructed in v-src has yielded several mutants that have relatively high levels of p6v-src kinase activity but are poorly transforming in Rat-2 cells (7). The XD6 and SHX13 mutants have alterations within highly conserved regions of the v-Src SH2 domain. XD6 has a deletion of residues 149-174, and the SHX13 mutation inserts Arg-Ala after residue 228. In con- trast, the SRX5 mutation replaces the codon for the Tyr-416 autophosphorylation site in the catalytic domain with codons for Ser-Arg-Asp. Rat-2 cells expressing these v-src mutants contained similar levels of GAP and p60-src compared with wild-type v-src-transformed cells (data not shown). However, anti-GAP immunoprecipitations showed that the tyrosine phosphorylation of GAP-associated p62, and of GAP itself, was greatly decreased in cells expressing the SHX13 and XD6 v-src SH2 mutants, correlating with their particularly low Rat-2 transforming activity (Fig. 4B) . In contrast, the SRX5 autophosphorylation site mutant has an intact SH2 domain, retains 13% of wild-type transforming activity on Rat-2 cells, and still gives appreciable phosphorylation of p62 and GAP. Unlike p62, which is a minor but highly phosphorylated protein, p190 contains relatively little phosphotyrosine but is a major GAP-binding protein (28 Our results indicate that SH2 domains allow these proteins to interact with a related, but limited, set of tyrosine phosphorylated ligands. SH2-binding proteins include activated receptor tyrosine kinases, exemplified by the EGFR, and substrates such as p62, p70, and p130. The ability of bacterially derived GAP or v-Crk SH2 domains to form complexes in vitro suggests that their phosphorylation is not required for ligand binding. Rather, the tyrosine phosphorylation of SH2-binding proteins, such as growth factor receptors and p62, is likely to regulate complex formation by increasing their affinities for SH2-containing proteins. In support of this notion, substitution of the PDGFR autophosphorylation sites with phenylalanine inhibits the PDGF-dependent association of GAP with the receptor (30) . We have subsequently observed that recombinant GAP and PLCy SH2 domains associate with the wild-type PDGFR in lysates of PDGFstimulated cells (37) . The simplest explanation of these results is that SH2 domains directly contact phosphotyrosine-containing ligands. However, until these interactions have been reconstituted by using purified proteins, it remains possible that they involve additional unphosphorylated proteins.
SH2 Domains May Regulate Protein-Protein Interactions in
Vivo. In the cell, the interactions of SH2 domains with phosphotyrosine-containing proteins may direct the formation of high-affinity complexes that facilitate signal transduction. Indeed, all the proteins identified as binding SH2 domains in vitro have been found in complexes with one or more SH2-containing proteins in vivo. For example, the ability of recombinant SH2 domains to associate with the activated EGFR suggests that they are responsible for the interactions of receptors with signaling proteins such as GAP and PLCy (24, 25, 30, 31) . In EGF-stimulated or srctransformed cells GAP forms a precipitable complex with a highly tyrosine phosphorylated protein, p62. p62 is an SH2-binding protein that associates efficiently with the N-terminal GAP SH2 domain in vitro. Tyrosine phosphorylation of p62 might increase its affinity for GAP-SH2 and allow it to displace other GAP-binding proteins, such as autophosphorylated receptors. The C-terminal region of GAP is known to associate with p21'S; the data presented here suggest that the more N-terminal SH2 domain interacts in trans with phosphotyrosine proteins such as growth factor receptors and p62. One possibility is that these complexes affect p2ls activity, although this hypothesis remains to be established. The v-Crk oncoprotein elevates cellular phosphotyrosine levels (11) and may transform cells by complexing with multiple phosphotyrosine-containing proteins (13, 14) . Consistent with this suggestion, TrpE-v-Crk showed a remarkable ability to complex with the tyrosine phosphorylated proteins p70 and p130 in a lysate from normal Rat-2 cells (Fig.   2B ).
Although SH2 domains from different proteins can interact with similar polypeptides in vitro, their binding specificities are not identical. The N-terminal GAP SH2 domain associated preferentially with p62, whereas v-Crk showed a higher affinity for p130 and p70. The functional complexes that form in vivo may reflect these different affinities. For example, GAP coimmunoprecipitates from src-transformed cells with p62 but not p130, which might be sequestered by other SH2-containing proteins. The various SH2 domains may also have distinct biological activities; thus, the high level expression of the GAP SH region does not transform fibroblasts, in contrast to v-crk (D.A. and G. Mbamalu, unpublished results). Protein-protein interactions induced by activated tyrosine kinases may, therefore, be regulated by two mechanisms. First, tyrosine phosphorylation may modulate the affinities of SH2-binding proteins for SH2 domains, thereby inducing the formation of complexes that initiate signal transduction. In addition, specific SH2 domains bind some phosphotyrosine-containing ligands better than others. This apparent specificity in SH2-ligand interactions may determine which proteins associate within the cell. SH2 Domains of Cytoplasmic Tyrosine Kinases Interact in Cis with the Catalytic Domain and in Trans with Substrates. The SH2 domain of p6Ov-src or P13W9a5-fPS is important both for the regulation of kinase activity and the phosphorylation of specific substrates. The v-Fps SH2 domain apparently interacts in cis with the neighboring kinase domain to modulate its kinase activity (9) . This association is augmented by autophosphorylation within the kinase domain (9) , consistent with the notion that SH2 domains recognize phosphotyrosine sites. The Src and Fps SH2 domains are also required for phosphorylation of the p62 SH2-binding protein that complexes with GAP in vivo. Hence, the v-Src SH2 domain may recognize and bind unphosphorylated p62 to facilitate its phosphorylation by the kinase domain. Alternatively, Src SH2 might play no direct role in phosphorylation of p62 by the kinase domain but might bind and protect the tyrosine phosphorylated products. A subsequent intramolecular interaction between the Src SH2 and kinase domains might then destabilize p62-Src or GAP-Src complexes, and allow p62 to associate with the GAP SH2 domain. In this scheme, Src SH2 can complex with its own kinase domain or with substrates such as p62 and may thereby control kinasesubstrate interactions. Regardless of the mechanism, the data indicate that p62 is recognized by v-Src in vivo. The ability of a noncatalytic protein kinase domain to recognize substrates of the enzymatic domain is unusual and sets cytoplasmic tyrosine kinases apart from their serine/threonine-specific counterparts. Furthermore, the v-src and v-fps mutants that fail to phosphorylate p62 and GAP are poorly transforming in Rat-2 cells, suggesting that one or both of these might be biologically important tyrosine kinase substrates.
